A2058 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The A2058 cell line is a human melanoma cell line derived from a brain metastasis of a patient with malignant melanoma. This cell line is widely used in cancer research due to its high metastatic potential, which makes it an important model for studying melanoma progression and the mechanisms underlying metastasis. A2058 cells are known to express nerve growth factor (NGF) receptors, which are linked to their aggressive and metastatic characteristics. One of the key features of A2058 cells is their ability to produce transforming growth factors (TGFs) that promote anchorage-independent growth, a common indicator of the transformed, cancerous phenotype. These TGFs interact with epidermal growth factor (EGF) receptors, despite the cells themselves lacking detectable EGF receptors. This interaction is critical for enabling the growth of normal fibroblasts and epithelial cells in soft agar, a standard assay for evaluating the transformation potential of cancer cells. A2058's ability to drive such growth highlights its utility in research focused on understanding and combating the spread of melanoma. |
|---|---|
| Organism | Human |
| Tissue | Skin |
| Disease | Amelanotic melanoma |
| Metastatic site | Lymph node |
| Synonyms | A 2058, A-2058 |
Characteristics
| Age | 43 years |
|---|---|
| Gender | Male |
| Ethnicity | European |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | A2058 (Cytion catalog number 305046) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1059 |
Biomolecular Data
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 27 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305046-220523 | Certificate of Analysis | 23. May. 2025 | 305046 |
| 305046-160125 | Certificate of Analysis | 23. May. 2025 | 305046 |